Biomarkers and AI could identify whether an individual primarily needs weight loss, stronger insulin sensitisation, beta-cell protection, surgery or combination therapy
Patients should always follow proper sharps disposal procedures afterward
Despite important knowledge gaps in our understanding of IR in T1D, targeting IR in overweight/obese patients with T1D may decrease the risk of diabetes complications, contribute to weight loss, and improve glycemic control
Enhancing hepatic MBOAT7 expression in mice with nonalcoholic steatohepatitis
Obesity and inflammation: the linking mechanism and the complications
However, such observations need to be considered as hypothesis generating, requiring testing in preclinical and clinical studies that confirm efficacy and ensure safety